OpenEvidence

Launched during the Mayo Clinic Platform Accelerate program, featured by the New England Journal of Medicine AI, and powering Elsevier’s ClinicalKey AI (Lancet; Cell; Gray's Anatomy; 2000+ journals), OpenEvidence is the world’s leading AI medical information platform.

OpenEvidence is the world’s leading medical information platform for health care professionals, providing accurate and efficient answers at the point of care. Every answer on OpenEvidence is always sourced, cited, and grounded in the peer-reviewed medical literature.

Now featuring New England Journal of Medicine (NEJM) published content, NEJM multimedia content, and NEJM invited review articles authored by the world’s leading clinical experts.

• 160 medical specialties

• 1,000+ diseases and therapeutic areas

• 1m+ medical topics

Trusted by medical professionals at 10,000+ care centers across the United States.

Investors include Sequoia Capital, Breyer Capital, Mayo Clinic, Elsevier, and others